Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cooper-Atkins is a long-established manufacturer of temperature management products, environmental measurement devices, and wireless monitoring solutions used across foodservice, food processing, healthcare, and industrial settings. The company is best known for thermometers, probes, thermistors, timers, and connected monitoring systems that support food safety, regulatory compliance, cold-chain oversight, and patient-safety workflows. Originally an independent company headquartered in Middlefield, Connecticut, Cooper-Atkins was acquired by Emerson in January 2018 and today is marketed as a brand within Copeland’s controls and monitoring portfolio. Its healthcare relevance is primarily in monitoring and compliance tools for hospitals, pharmacies, laboratories, and other environments where temperature and humidity control are critical. This is not a drug-development biotech or pharma company; it is a commercial device and monitoring-solutions business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cooper-Atkins.